Department of Pharmacology, School of Basic Medicine, Zhengzhou University (Y.-L.N., J.-Y.L., L.Y., P.W., H.-Z.B., L.-R.Z.); Laboratory of Cardiovascular Disease and Drug Research, Seventh People's Hospital of Zhengzhou (X.-G.M.); Department of Clinical Pharmacology, First Affiliated Hospital, Zhengzhou University (Q.-C.K.), Zhengzhou, People's Republic of China.
Department of Pharmacology, School of Basic Medicine, Zhengzhou University (Y.-L.N., J.-Y.L., L.Y., P.W., H.-Z.B., L.-R.Z.); Laboratory of Cardiovascular Disease and Drug Research, Seventh People's Hospital of Zhengzhou (X.-G.M.); Department of Clinical Pharmacology, First Affiliated Hospital, Zhengzhou University (Q.-C.K.), Zhengzhou, People's Republic of China
Drug Metab Dispos. 2017 Dec;45(12):1372-1378. doi: 10.1124/dmd.117.076109. Epub 2017 Oct 12.
Human UDP-glucuronosyltransferase 1A1 (UGT1A1) is a unique enzyme involved in bilirubin conjugation. We previously characterized the hepatic expression of transcription factors affecting UGT1A1 expression during development. Accordingly, in this study, we characterized the ontogenetic expression of hepatic UGT1A1 from the perspective of epigenetic regulation. We observed significant histone-3-lysine-4 dimethylation (H3K4me2) enrichment in the adult liver and histone-3-lysine-27 trimethylation (H3K27me3) enrichment in the fetal liver, indicating that dynamic alterations of histone methylation were associated with ontogenetic UGT1A1 expression. We further showed that the transcription factor hepatocyte nuclear factor 1 (HNF1A) affects histone modifications around the locus. In particular, we demonstrated that by recruiting HNF1A the cofactors mixed-lineage leukemia 1, the transcriptional coactivator p300, and nuclear receptor coactivator 6 aggregate at the promoter, thereby regulating histone modifications and subsequent UGT1A1 expression. In this study, we proposed new ideas for the developmental regulation of metabolic enzymes via histone modifications, and our findings will potentially contribute to the development of age-specific therapies.
人类 UDP-葡糖醛酸基转移酶 1A1(UGT1A1)是一种参与胆红素结合的独特酶。我们之前已经对影响发育过程中 UGT1A1 表达的转录因子的肝表达进行了特征描述。因此,在这项研究中,我们从表观遗传调控的角度描述了肝 UGT1A1 的个体发生表达。我们观察到成年肝脏中存在显著的组蛋白 3-赖氨酸-4 二甲基化(H3K4me2)富集,以及胎儿肝脏中存在组蛋白 3-赖氨酸-27 三甲基化(H3K27me3)富集,这表明组蛋白甲基化的动态变化与个体发生的 UGT1A1 表达有关。我们进一步表明,转录因子肝细胞核因子 1(HNF1A)影响 基因座周围的组蛋白修饰。具体来说,我们证明了通过募集 HNF1A,共激活因子混合谱系白血病 1、转录共激活因子 p300 和核受体共激活因子 6 聚集在 启动子上,从而调节组蛋白修饰和随后的 UGT1A1 表达。在这项研究中,我们提出了通过组蛋白修饰调节代谢酶的发育调控的新观点,我们的发现可能为特定年龄的治疗方法的发展做出贡献。